CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for GC Medical Science Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

GC Medical Science Corp
(Bojeong-dong) 15
Yonggu-daero 2469beon-gil, Giheung-gu
Phone: +82 312609300p:+82 312609300 YONGIN, 16907  South Korea Ticker: 142280142280
Business Summary
GC Medical Science Corp, formerly Green Cross Medical Science Corp, is a Korea-based company primarily engaged in the manufacture and sale of diagnostic reagents. The Company operates its business through four segments. The Diagnostic Reagents segment mainly manufactures and sells diagnostic reagents related to disease diagnosis, prognosis and treatment, including immunodiagnostics, clinical chemistry diagnostics and molecular diagnostics. This segment also provides home healthcare products and medical consumables. The Hemodialysis Fluid segment primarily manufactures and sells perfusion fluids for artificial kidney dialysis used in patients with chronic renal failure. The Blood Glucose segment primarily manufactures and sells medical devices, including blood glucose meters and HbA1c analyzers. The Other segment primarily offers other services.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202512/31/2025Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3841 Surgical and medical instruments and apparatus
3826 Laboratory analytical instruments
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Yeong HuiSah Gong 58 3/28/2022 3/28/2022
Assistant Managing Director Seung EulBaek 52
Internal Auditor Sang SunHwang 60
Assistant Managing Director Yeong SeokPark 51
Non-Executive Independent Director Jong RakChoi 51

General Information
Number of Employees: 175 (As of 12/31/2015)
Outstanding Shares: 21,741,926 (As of 12/31/2025)
Shareholders: 19,414
Stock Exchange: KDQ
Fax Number: +82 312609416


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, May 13, 2026